Is Chinese Thyroid Imaging Reporting and Data Systems superior to American College of Radiology or American Thyroid Association guidelines for consistency and efficacy in the diagnosis of thyroid cancer?

Na Li,Ying He,Ruijao Chang

DOI: https://doi.org/10.1097/cm9.0000000000002061

IF: 6.133

2022-10-08

Chinese Medical Journal

Abstract:To the Editor: The incidence of thyroid nodule has significantly increased in the past 30 years. As an important modality for thyroid screening and examination, ultrasound can be used to differentiate malignant from benign thyroid nodules. With the continuous improvement of the resolution of ultrasound, an increasing number of small nodules have been detected, especially nodules <1 cm. However, the misdiagnosis of thyroid nodules increases the incidence of unnecessary biopsies. [1] Therefore, the accurate distinction of malignant from benign thyroid nodules is essential to reduce the rate of unnecessary biopsy. At present, several thyroid imaging reporting and data systems (TI-RADSs) have been used to unify thyroid nodule reporting terms and provide recommendations for ultrasound examination. The American College of Radiology TI-RADS (ACR-TIRADS) [2] and American Thyroid Association (ATA)-2015 guide-lines [3] are widely used in China. In 2020, China issued the Chinese TI-RADS (C-TIRADS) [4] based on Chinese national and medical conditions. Although many studies have compared the TI-RADS guidelines, the interobserver agreement of C-TIRADS and interguideline agreement between C-TIRADS and other guidelines remain unclear. In addition, whether C-TIRADS, as a newly released guideline, is more accurate than ACR-TIRADS and the ATA guidelines in the diagnosis of thyroid nodules in the Chinese population has not been discussed. We compared the diagnostic efficacy and interobserver and interguideline agreement between C-TIRADS and two other guidelines in distinguishing thyroid cancer and to provide a basis for the clinical application of C-TIRADS.

medicine, general & internal